Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-09 Purchase |
2024-07-11 4:15 pm |
Alto Neuroscience Inc. | ANRO | Savitz Adam CHIEF MEDICAL OFFICER |
15,000 | $12.72 | $190,833 | 39,851 (Indirect) |
View |
| 2024-03-28 Purchase |
2024-04-01 4:15 pm |
Alto Neuroscience Inc. | ANRO | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER |
6,150 | $16.36 | $100,628 | 26,866 (Direct) |
View |
| 2024-02-06 Purchase |
2024-02-08 4:32 pm |
Alto Neuroscience Inc. | ANRO | Alpha Wave Global LP Alpha Wave Ventures GP Ltd Lunate Holding RSC Ltd Chimera Investment LLC 10% Owner |
600,000 | $16 | $9,600,000 | 3,707,757 (Indirect) |
View |
| 2024-02-06 Purchase |
2024-02-07 4:40 pm |
Alto Neuroscience Inc. | ANRO | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER |
1,563 | $16 | $25,008 | 1,563 (Direct) |
View |
| 2024-02-06 Purchase |
2024-02-07 4:38 pm |
Alto Neuroscience Inc. | ANRO | Savitz Adam CHIEF MEDICAL OFFICER |
17,000 | $16 | $272,000 | 24,851 (Indirect) |
View |
| 2024-02-06 Purchase |
2024-02-07 4:36 pm |
Alto Neuroscience Inc. | ANRO | Etkin Amit PRESIDENT AND CEO |
3,125 | $16 | $50,000 | 1,205,465 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-05 Option Award |
2025-02-07 4:22 pm |
N/A 2035-02-04 |
Alto Neuroscience Inc. | ANRO | Hanley Jr. Michael Conick CHIEF OPERATING OFFICER |
125,000 | $0 | 125,000 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:22 pm |
N/A 2035-02-04 |
Alto Neuroscience Inc. | ANRO | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO |
135,000 | $0 | 135,000 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:21 pm |
N/A 2035-02-04 |
Alto Neuroscience Inc. | ANRO | Savitz Adam CHIEF MEDICAL OFFICER |
76,000 | $0 | 76,000 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:21 pm |
N/A 2035-02-04 |
Alto Neuroscience Inc. | ANRO | Etkin Amit PRESIDENT AND CEO |
215,000 | $0 | 215,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:18 pm |
N/A 2035-01-01 |
Alto Neuroscience Inc. | ANRO | York Gwill Director |
19,558 | $3.17 | 19,558 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:17 pm |
N/A 2035-01-01 |
Alto Neuroscience Inc. | ANRO | Manji Husseini Director |
14,195 | $3.17 | 14,195 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:17 pm |
N/A 2035-01-01 |
Alto Neuroscience Inc. | ANRO | Cox Christopher Nixon Director |
25,236 | $3.17 | 25,236 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-22 5:19 pm |
N/A 2034-05-19 |
Alto Neuroscience Inc. | ANRO | Hanley Jr. Michael Conick Chief Operating Officer |
188,000 | $0 | 188,000 (Direct) |
View |
Ownership |
2024-05-22 5:17 pm |
N/A 2034-02-28 |
Alto Neuroscience Inc. | ANRO | Hanley Jr. Michael Conick Chief Operating Officer |
0 | $0 | 8,000 (Direct) |
View |
| 2024-03-08 Option Award |
2024-03-12 4:49 pm |
N/A 2034-03-07 |
Alto Neuroscience Inc. | ANRO | Radhakrishnan Maha Director |
1,590 | $10.21 | 32,164 (Direct) |
View |
| 2024-03-08 Option Award |
2024-03-12 4:49 pm |
N/A 2034-03-07 |
Alto Neuroscience Inc. | ANRO | Radhakrishnan Maha Director |
30,574 | $0 | 32,164 (Direct) |
View |
| 2024-02-06 Conversion |
2024-03-06 09:15 am |
N/A N/A |
Alto Neuroscience Inc. | ANRO | Apeiron Investment Group Ltd. Apeiron Presight Capital Fund II L.P. Angermayer Christian See Remarks |
3,257,755 | $0 | 926,539 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 6:00 pm |
N/A 2034-02-28 |
Alto Neuroscience Inc. | ANRO | Savitz Adam CHIEF MEDICAL OFFICER |
73,000 | $0 | 73,000 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 6:00 pm |
N/A 2034-02-28 |
Alto Neuroscience Inc. | ANRO | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER |
109,153 | $0 | 110,716 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 6:00 pm |
N/A 2034-02-28 |
Alto Neuroscience Inc. | ANRO | Etkin Amit PRESIDENT AND CEO |
257,711 | $0 | 1,463,176 (Direct) |
View |
| 2024-02-06 Conversion |
2024-02-08 4:32 pm |
N/A N/A |
Alto Neuroscience Inc. | ANRO | Alpha Wave Global LP Alpha Wave Ventures GP Ltd Lunate Holding RSC Ltd Chimera Investment LLC 10% Owner |
4,252,520 | $0 | 3,707,757 (Indirect) |
View |
| 2024-02-06 Conversion |
2024-02-07 4:41 pm |
N/A N/A |
Alto Neuroscience Inc. | ANRO | York Gwill Director |
77,113 | $0 | 23,917 (Direct) |
View |
| 2024-02-06 Conversion |
2024-02-07 4:39 pm |
N/A N/A |
Alto Neuroscience Inc. | ANRO | Cox Christopher Nixon Director |
2,247,570 | $0 | 715,653 (Indirect) |
View |
| 2024-02-06 Conversion |
2024-02-07 4:38 pm |
N/A N/A |
Alto Neuroscience Inc. | ANRO | Savitz Adam CHIEF MEDICAL OFFICER |
24,517 | $0 | 24,851 (Indirect) |
View |
| 2024-02-06 Conversion |
2024-02-07 4:36 pm |
N/A N/A |
Alto Neuroscience Inc. | ANRO | Etkin Amit PRESIDENT AND CEO |
36,777 | $0 | 1,205,465 (Direct) |
View |
| 2024-02-06 Conversion |
2024-02-07 4:35 pm |
N/A N/A |
Alto Neuroscience Inc. | ANRO | Chen Po Yu (Jeff) Director |
149,836 | $0 | 47,709 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:47 pm |
N/A 2034-01-31 |
Alto Neuroscience Inc. | ANRO | York Gwill Director |
3,083 | $11.88 | 33,657 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:47 pm |
N/A 2034-01-31 |
Alto Neuroscience Inc. | ANRO | York Gwill Director |
30,574 | $0 | 33,657 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:45 pm |
N/A 2034-01-31 |
Alto Neuroscience Inc. | ANRO | Manji Husseini Director |
3,083 | $11.88 | 33,657 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:45 pm |
N/A 2034-01-31 |
Alto Neuroscience Inc. | ANRO | Manji Husseini Director |
30,574 | $0 | 33,657 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:43 pm |
N/A 2034-01-31 |
Alto Neuroscience Inc. | ANRO | Chen Po Yu (Jeff) Director |
1,540 | $11.88 | 32,114 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:43 pm |
N/A 2034-01-31 |
Alto Neuroscience Inc. | ANRO | Chen Po Yu (Jeff) Director |
30,574 | $0 | 32,114 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:42 pm |
N/A 2034-01-31 |
Alto Neuroscience Inc. | ANRO | Cox Christopher Nixon Director |
4,623 | $11.88 | 35,197 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:42 pm |
N/A 2034-01-31 |
Alto Neuroscience Inc. | ANRO | Cox Christopher Nixon Director |
30,574 | $0 | 35,197 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:40 pm |
N/A 2034-01-31 |
Alto Neuroscience Inc. | ANRO | Dreyfus Andrew Director |
30,574 | $0 | 30,574 (Direct) |
View |
Ownership |
2024-02-02 4:54 pm |
N/A N/A |
Alto Neuroscience Inc. | ANRO | Apeiron Investment Group Ltd. Angermayer Christian Apeiron Presight Capital Fund II L.P. 10% Owner |
0 | $0 | 2,933,173 (Direct) |
View |
Ownership |
2024-02-01 6:53 pm |
N/A 2033-10-11 |
Alto Neuroscience Inc. | ANRO | Dreyfus Andrew Director |
0 | $0 | 22,481 (Direct) |
View |
Ownership |
2024-02-01 6:53 pm |
N/A N/A |
Alto Neuroscience Inc. | ANRO | Alpha Wave Ventures GP Ltd Alpha Wave Global LP Lunate Holding RSC Ltd Chimera Investment LLC 10% Owner |
0 | $0 | 3,107,757 (Indirect) |
View |
Ownership |
2024-02-01 6:52 pm |
N/A N/A |
Alto Neuroscience Inc. | ANRO | Etkin Amit President and CEO |
0 | $0 | 1,641,617 (Direct) |
View |
Ownership |
2024-02-01 6:50 pm |
N/A N/A |
Alto Neuroscience Inc. | ANRO | York Gwill Director |
0 | $0 | 68,878 (Direct) |
View |
Ownership |
2024-02-01 6:48 pm |
N/A 2031-09-08 |
Alto Neuroscience Inc. | ANRO | Smith Nicholas Conrad Chief Financial Officer |
0 | $0 | 416,010 (Direct) |
View |
Ownership |
2024-02-01 6:47 pm |
N/A N/A |
Alto Neuroscience Inc. | ANRO | ALKEON CAPITAL MANAGEMENT LLC See Remarks |
0 | $0 | 477,101 (Direct) |
View |
Ownership |
2024-02-01 6:47 pm |
N/A N/A |
Alto Neuroscience Inc. | ANRO | Cox Christopher Nixon Director |
0 | $0 | 715,653 (Indirect) |
View |
Ownership |
2024-02-01 6:45 pm |
N/A N/A |
Alto Neuroscience Inc. | ANRO | Savitz Adam Chief Medical Officer |
0 | $0 | 321,871 (Indirect) |
View |
Ownership |
2024-02-01 6:43 pm |
N/A N/A |
Alto Neuroscience Inc. | ANRO | Chen Po Yu (Jeff) Director |
0 | $0 | 47,709 (Direct) |
View |